George Goshua

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 46

Top Topics

Sickle Cell Disease

Acute Myeloid Leukemia

Pulmonary Embolism

Top Venues

American journal of hematology

Leukemia & lymphoma

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua
Cost-effectiveness of sutimlimab in cold agglutinin disease. American journal of hematology 99 (8) (2024)
Christina J Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua
Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States. Blood 143 (22) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Christina J Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua
Cost-effectiveness of prophylaxis with recombinant versus plasma-derived VWF in severe von Willebrand disease in the US. Blood (2024)
Jan Philipp Bewersdorf, Kishan K Patel, Rory Michael Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3- mutant acute myeloid leukemia. Leukemia & lymphoma (2024)
Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua
Cost-effectiveness of sutimlimab in cold agglutinin disease. American journal of hematology 99 (8) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
George Goshua
Limitless. Journal of general internal medicine (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Jan Philipp Bewersdorf, Kishan K Patel, Rory Michael Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3- mutant acute myeloid leukemia. Leukemia & lymphoma 65 (8) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Jan Philipp Bewersdorf, Kishan K Patel, Rory Michael Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3- mutant acute myeloid leukemia. Leukemia & lymphoma 65 (8) (2024)
George Goshua
Limitless. Journal of general internal medicine 39 (11) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs. in-house vs. send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Jan Philipp Bewersdorf, Kishan K Patel, Rory Michael Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3- mutant acute myeloid leukemia. Leukemia & lymphoma 65 (8) (2024)
George Goshua
Limitless. Journal of general internal medicine 39 (11) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances (2024)
Jan Philipp Bewersdorf, Kishan K Patel, Rory Michael Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3- mutant acute myeloid leukemia. Leukemia & lymphoma 65 (8) (2024)
Christina J Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua
Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States. Blood 143 (22) (2024)
Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua
Cost-effectiveness of sutimlimab in cold agglutinin disease. American journal of hematology (2024)
George Goshua, Alfred Ian Lee
Summiting thrombotic hazards in glioma. Blood 141 (11) (2023)
George Goshua, Alfred Ian Lee
Summiting thrombotic hazards in glioma. Blood 141 (11) (2023)
Ayesha Butt, Cecily Allen, Adriana Purcell, Satoko Ito, George Goshua
Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP). Journal of clinical medicine 12 (15) (2023)
Christina Waldron, George Goshua
Splenectomy reappraised: Bridging the gap in immune cytopenia treatment paradigms. Journal of internal medicine (2023)
George Goshua, Cecelia L Calhoun, Satoko Ito, Lyndon P James, Andrea Luviano, Lakshmanan Krishnamurti, Ankur Pandya
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States. Annals of internal medicine (2023)
Kunal C Potnis, Giri Viswanathan, Robert D Bona, Satoko Ito, Christine L Kempton, Ankur Pandya, Harlan M Krumholz, George Goshua
Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States. American journal of hematology (2023)
Satoko Ito, George Goshua
Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis. Annals of internal medicine (2022)
George Goshua, Pranay Sinha, Natalia Kunst, Lauren Pischel, Alfred Ian Lee, Adam Cuker
Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia. American journal of hematology (2022)
Satoko Ito, George Goshua
Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis. Annals of internal medicine 176 (1) (2022)
Satoko Ito, George Goshua
Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis. Annals of internal medicine 176 (1) (2022)
Lauren Pischel, Kavin M Patel, George Goshua, Saad B Omer
Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 75 (7) (2022)
Satoko Ito, George Goshua
Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis. Annals of internal medicine 176 (1) (2022)
George Goshua, Alfred Ian Lee
Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID-19. Research and practice in thrombosis and haemostasis 5 (1) (2021)
George Goshua, Ayesha Butt, Alfred I Lee
Immunothrombosis: a COVID-19 concerto. British journal of haematology 194 (3) (2021)
Lauren Pischel, George Goshua
Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (11) (2021)
Matthew L Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Y Wang, Christina Price, Robert D Bona, Cassius Iyad Ochoa Chaar, Hyung J Chun, Alexander B Pine, Henry M Rinder, Jonathan M Siner, Donna S Neuberg, Kent A Owusu, Alfred Ian Lee
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. American journal of hematology 96 (4) (2021)